102 related articles for article (PubMed ID: 6421346)
1. Characterization of the thrombin-induced contraction of vascular smooth muscle.
Haver VM; Namm DH
Blood Vessels; 1984; 21(2):53-63. PubMed ID: 6421346
[TBL] [Abstract][Full Text] [Related]
2. Generation of a vasoactive substance in human plasma during coagulation. Evidence of thrombin-induced contraction of rabbit aorta and dog coronary artery.
Haver VM; Namm DH
Blood Vessels; 1983; 20(2):92-8. PubMed ID: 6824792
[TBL] [Abstract][Full Text] [Related]
3. The contractile response of vascular smooth muscle to thrombin and its inhibition by thrombin inhibitors.
Glusa E; Wolfram U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):94-100. PubMed ID: 2459039
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the de-endothelialized rabbit aorta in vitro.
Hatton MW; Moar SL
Thromb Haemost; 1991 Aug; 66(2):208-12. PubMed ID: 1771613
[TBL] [Abstract][Full Text] [Related]
6. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
[TBL] [Abstract][Full Text] [Related]
7. Effect of LY287045, a thrombin/trypsin inhibitor, on thrombin and trypsin-induced aortic contraction and relaxation.
Bhattacharya A; Smith GF; Cohen ML
J Pharmacol Exp Ther; 2001 May; 297(2):573-81. PubMed ID: 11303045
[TBL] [Abstract][Full Text] [Related]
8. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
9. Effect of thrombin on isolated canine blood vessels.
Janssens WJ; Verhaeghe RH
Blood Vessels; 1982; 19(3):126-34. PubMed ID: 7074226
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of diltiazem and nitroglycerin on cytosolic Ca2+ concentration and on force in the bovine ophthalmic artery.
Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2612-23. PubMed ID: 8977475
[TBL] [Abstract][Full Text] [Related]
11. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled r-hirudin as a measure of thrombin activity at, or within, the rabbit aorta wall in vitro and in vivo.
Hatton MW; Ross-Ouellet B
Thromb Haemost; 1994 Apr; 71(4):499-506. PubMed ID: 8052970
[TBL] [Abstract][Full Text] [Related]
13. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
14. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
Antonaccio MJ; Normandin D; Serafino R; Moreland S
J Pharmacol Exp Ther; 1993 Jul; 266(1):125-32. PubMed ID: 8331553
[TBL] [Abstract][Full Text] [Related]
15. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein.
Alexander JJ; Lewis I
J Surg Res; 2002 Mar; 103(1):41-6. PubMed ID: 11855916
[TBL] [Abstract][Full Text] [Related]
16. Different inhibition by vasodilators of coronary artery contraction.
Inoue S; Kinoshita M; Toda N
Arch Int Pharmacodyn Ther; 1988; 295():181-93. PubMed ID: 3245734
[TBL] [Abstract][Full Text] [Related]
17. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
18. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
Dong Y; Ishikawa H; Wu Y; Yoshitomi T
Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
[TBL] [Abstract][Full Text] [Related]
19. Role of plasmin, thrombin, and antithrombin III as etiological factors in delayed cerebral vasospasm.
White RP; Robertson JT
Neurosurgery; 1985 Jan; 16(1):27-35. PubMed ID: 2579347
[TBL] [Abstract][Full Text] [Related]
20. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery.
Choi SK; Ahn DS; Lee YH
Cardiovasc Res; 2009 May; 82(2):324-32. PubMed ID: 19218288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
